A-A-51526A
23 July 1987
COMMERCIAL ITEM DESCRIPTION
NORETHINDRONE AND MESTPANOL TABLETS, USP, 63s
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics:
Shall be Norethindrone and Mestranol Tablets, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of pharmaceutical grade.
Shall contain 1.0 mg of Norethindrone and 0.05 mg Mestranol per tablet, within the applicable assay limits for tablets.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Box (BX).
Shall be supplied 21 tablets in a blister-type package designed to fit into a plastic compact/wallette dispenser. One box containing 3 blister packages and 1 compact/wallette dispenser (63 tablets), as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business